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Introduction
Systemic juvenile idiopathic arthritis (sJIA) shares clini-
cal features with classic monogenic autoinflammatory
diseases, characterised by fevers, arthritis and evanescent
rashes. Disease exacerbations are associated with ele-
vated serum cytokine levels including 1L-1b, IL-6, and
IL-18; and clinical response to anakinra, canakinumab
and tocilizumab suggests that cytokine dysregulation is a
key pathophysiological mechanism. Macrophage activa-
tion syndrome (MAS) may complicate sJIA, rendering
individuals clinically indistinguishable from their familial
haemophagocytic lymphohistiocytosis (fHLH) counter-
parts; with NK and CD8+ cell dysfunction leading to
sustained immune cell activation and cytokine storm.
Whilst there have been HLA associations and poly-
morphisms noted on sJIA genome-wide association stu-
dies, in rare cases mutations have been found in genes
encoding key components of the inflammatory response,
which may contribute to disease pathogenesis.
Objectives
We aim to identify rare variants in innate immune genes
that contribute to cytokine imbalance and lead to the
inflammatory phenotype seen in sJIA patients.
Methods
We performed whole exome sequencing on probands
with sJIA and their parents (trios). Recessive, com-
pound heterozygous and de novo inheritance models
were tested and variants evaluated for potential func-
tional effect using a combination of SIFT, PolyPhen
and MutationTaster. We confirmed candidate patho-
genic variants by Sanger sequencing and cross-checked
these variants with the Infevers database, known fHLH
causing mutations and inflammatory pathways. We
harnessed CRISPR-Cas9 gene editing technology to
model mutations in appropriate cell lines, and investi-
gate the pathogenic nature of identified novel variants.
Results
Exome sequencing was performed on a total of 16
trios and unaffected siblings, with data from 13 trios
suitable for analysis. There were no rare variants or
indels inherited in a dominant, recessive or compound
heterozygous manner, and predicted to affect function
in a known inflammatory pathway. Furthermore, rare
variants with predicted functional effects in Infever
genes or fHLH genes were not identified. In total,
there were 26 de novo variants (median = 2, range 0
to 6 per trio), with 17 of these predicted to affect pro-
tein function (median = 1, range 0 to 2 per trio). At
least one de novo variant affects a known innate
immune gene, and the pathogenic nature of this var-
iant is being confirmed in vitro.
Conclusion
Disease in a small subset of patients with sJIA may be
accounted for by rare de novo variants, however this
requires further in vitro confirmation. Alternatively, it is
possible that some of these individuals may in fact repre-
sent a separate disease entity.
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